Rituximab for Non-Hodgkin's Lymphoma: A Story of Rapid Success in Translation

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1

(2013) Daniel E Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

Which are the antibodies to watch in 2013?

(2013) Janice M. Reichert   mAbs

Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls

(2012) A. S. Bradley et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Non-Hodgkin lymphoma

(2012) Kate R Shankland et al.   LANCET

NICE guidance on rituximab for first-line treatment of symptomatic stage III–IV follicular lymphoma in previously untreated patients

(2012) Sally Doss et al.   LANCET ONCOLOGY

Monoclonal antibodies: magic bullets with a hefty price tag

(2012) A. F. Shaughnessy   BMJ-British Medical Journal

Pathogenesis of Non-Hodgkin's Lymphoma

(2011) Hendrik Nogai et al.   JOURNAL OF CLINICAL ONCOLOGY

Landmark lupus approval opens door for next wave of drugs

(2011)   NATURE REVIEWS DRUG DISCOVERY

2010 FDA drug approvals

(2011) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

(2011) Øystein Fluge et al.   PLoS One

Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals

(2011) P. D. W. Kiely et al.   RHEUMATOLOGY

Development trends for human monoclonal antibody therapeutics

(2010) Aaron L. Nelson et al.   NATURE REVIEWS DRUG DISCOVERY

Data exclusivity for biologics

(2010) Henry Grabowski et al.   NATURE REVIEWS DRUG DISCOVERY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

(2010) Joshua A. Ray et al.   VALUE IN HEALTH

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series

(2009) Øystein Fluge et al.   BMC Neurology

A review of the current use of rituximab in autoimmune diseases

(2008) Hakan M. Gürcan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The Meaning of Translational Research and Why It Matters

(2008) Steven H. Woolf   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

(2008) Robert Marcus et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE